東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

New mechanisms of transcriptional re...

Shatnawi, Aymen.

Linked to FindBook

Google Book

Amazon

博客來

New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors./
Author:	Shatnawi, Aymen.
Description:	231 p.
Notes:	Adviser: Manohar Ratnam.
Contained By:	Dissertation Abstracts International69-01B.
Subject:	Health Sciences, Pharmacology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3298777
ISBN:	9780549428268

New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors.
Shatnawi, Aymen.

New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors. - 231 p.

Adviser: Manohar Ratnam.

Thesis (Ph.D.)--Medical College of Ohio, 2008.

The folate receptor alpha (FR-alpha) is a cell surface protein that expressed in tissue selective manner and is capable of transporting folate, antifolates and folate conjugated molecules and nanoparticles into the cells. In contrast to the normal tissues where its expression is limited to the apical surface of epithelial tissues and isolated from the bloodstream, FR-alpha is over-expressed in certain gynecological tumors such as ovarian cancer where it is highly accessible via the circulation. Therefore, FR-alpha is a promising means for selective tumor targeting.

ISBN: 9780549428268Subjects--Topical Terms:

1017717
Health Sciences, Pharmacology.

New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors.
LDR:03067nam 2200277 a 45 001 938986
005 20110512
008 110512s2008 eng d
020 $a 9780549428268
035 $a (UMI)AAI3298777
035 $a AAI3298777
040 $a UMI $c UMI
100 1 $a Shatnawi, Aymen. $3 1262965
245 1 0 $a New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid receptors.
300 $a 231 p.
500 $a Adviser: Manohar Ratnam.
500 $a Source: Dissertation Abstracts International, Volume: 69-01, Section: B, page: 0250.
502 $a Thesis (Ph.D.)--Medical College of Ohio, 2008.
520 $a The folate receptor alpha (FR-alpha) is a cell surface protein that expressed in tissue selective manner and is capable of transporting folate, antifolates and folate conjugated molecules and nanoparticles into the cells. In contrast to the normal tissues where its expression is limited to the apical surface of epithelial tissues and isolated from the bloodstream, FR-alpha is over-expressed in certain gynecological tumors such as ovarian cancer where it is highly accessible via the circulation. Therefore, FR-alpha is a promising means for selective tumor targeting.
520 $a We have shown that the glucocorticoid (GR) and progesterone (PR) receptors positively regulate FR-alpha gene expression in cell culture and in tumor xenograft models. The expression of FR-alpha is enhanced further by combination of GR agonist with well-tolerated HDAC inhibitors such as valproic acid (VPA). Time course experiments and the use of protein synthesis inhibitor cycloheximide, showed that GR, PR-A and PR-B up-regulate FR-alpha expression indirectly in a ligand dependent manner. The promoter analysis of the FR-alpha gene showed the involvement of the G/C-rich Sp1 binding sites of the P4 promoter for the action of GR and PR and regulation by both receptors was optimal in the proper initiator context. Interestingly, the classical GR and PR receptor antagonist RU486 also activates FR-alpha expression but only through PR-B. Similar observations were made for PR regulation of the genes encoding p27, thymidine kinase 1, and p21. The results support the concept of increasing FR-alpha expression selectively in the receptor-positive tumors by brief treatment with a nontoxic dose of a GR and PR agonist, alone or in combination with a well-tolerated HDAC inhibitor, to increase the efficacy of various FR-alpha-dependent therapeutic and diagnostic applications. In addition, our findings contradict the current view of Sp1-dependent gene regulation by PR and point to the existence of one or more PR target genes whose promoter and cell context(s) must be key determinants of the agonistic activity of RU486 on a large group of important Sp1-dependent downstream target genes.
590 $a School code: 0539.
650 4 $a Health Sciences, Pharmacology. $3 1017717
690 $a 0419
710 2 0 $a Medical College of Ohio. $3 1262966
773 0 $t Dissertation Abstracts International $g 69-01B.
790 $a 0539
790 1 0 $a Ratnam, Manohar, $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3298777